DE68925043D1 - Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern - Google Patents

Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern

Info

Publication number
DE68925043D1
DE68925043D1 DE68925043T DE68925043T DE68925043D1 DE 68925043 D1 DE68925043 D1 DE 68925043D1 DE 68925043 T DE68925043 T DE 68925043T DE 68925043 T DE68925043 T DE 68925043T DE 68925043 D1 DE68925043 D1 DE 68925043D1
Authority
DE
Germany
Prior art keywords
amino acid
hiv
sequence starting
mixtures
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68925043T
Other languages
English (en)
Other versions
DE68925043T2 (de
DE68925043T3 (de
Inventor
Francesco Bellini
Gervais Dionne
Martial Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adaltis Inc
Original Assignee
IAF BioChem International Inc
Biochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27386744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68925043(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/148,821 external-priority patent/US6218102B1/en
Priority claimed from US07/281,205 external-priority patent/US6214537B1/en
Application filed by IAF BioChem International Inc, Biochem Pharma Inc filed Critical IAF BioChem International Inc
Application granted granted Critical
Publication of DE68925043D1 publication Critical patent/DE68925043D1/de
Publication of DE68925043T2 publication Critical patent/DE68925043T2/de
Publication of DE68925043T3 publication Critical patent/DE68925043T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68925043T 1988-01-27 1989-01-26 Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern Expired - Lifetime DE68925043T3 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US148821 1988-01-27
US07/148,821 US6218102B1 (en) 1988-01-27 1988-01-27 Synthetic peptides and mixtures thereof for detecting HIV antibodies
US18551888A 1988-04-22 1988-04-22
US185518 1988-04-22
US281205 1988-12-07
US07/281,205 US6214537B1 (en) 1988-01-27 1988-12-08 Synthetic peptides and mixtures thereof for detecting HIV antibodies

Publications (3)

Publication Number Publication Date
DE68925043D1 true DE68925043D1 (de) 1996-01-25
DE68925043T2 DE68925043T2 (de) 1996-08-22
DE68925043T3 DE68925043T3 (de) 2005-07-28

Family

ID=27386744

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925043T Expired - Lifetime DE68925043T3 (de) 1988-01-27 1989-01-26 Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern

Country Status (7)

Country Link
EP (1) EP0326490B2 (de)
JP (3) JPH01224397A (de)
AT (1) ATE131492T1 (de)
AU (1) AU629528B2 (de)
DE (1) DE68925043T3 (de)
ES (1) ES2083387T5 (de)
IL (1) IL88963A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
GB8828098D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8828097D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern
EP0438332B1 (de) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
WO1991015512A2 (en) * 1990-04-03 1991-10-17 Genentech, Inc. Hiv envelope polypeptides
NZ243636A (en) * 1991-07-29 1993-06-25 Iaf Biochem Int Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
AU671623B2 (en) * 1992-03-06 1996-09-05 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and biotinylated peptides used therein
JP4278174B2 (ja) * 1994-10-20 2009-06-10 アンスティテュ・パストゥール Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
FR2874017B1 (fr) * 2004-08-06 2006-11-24 Bio Rad Pasteur Sa Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
EP2778681A1 (de) * 2013-03-15 2014-09-17 Biomay Ag Verfahren zur Diagnose einer Virusinfektion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
EP0309566B1 (de) * 1987-04-16 1994-01-12 Johnson And Johnson Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden
JPH0215098A (ja) * 1987-05-18 1990-01-18 Virovahl Sa Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser

Also Published As

Publication number Publication date
ATE131492T1 (de) 1995-12-15
IL88963A (en) 1996-05-14
ES2083387T3 (es) 1996-04-16
EP0326490A3 (en) 1990-07-04
EP0326490B2 (de) 2004-11-24
JP2001055400A (ja) 2001-02-27
DE68925043T2 (de) 1996-08-22
AU2851389A (en) 1989-07-27
DE68925043T3 (de) 2005-07-28
ES2083387T5 (es) 2005-07-01
IL88963A0 (en) 1989-08-15
AU629528B2 (en) 1992-10-08
JP3851761B2 (ja) 2006-11-29
EP0326490A2 (de) 1989-08-02
JPH01224397A (ja) 1989-09-07
JPH08245693A (ja) 1996-09-24
EP0326490B1 (de) 1995-12-13

Similar Documents

Publication Publication Date Title
LU91014I2 (fr) Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base
DE68925043D1 (de) Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern
ATE144993T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
NO911787D0 (no) Peptidaminer samt fremgangsmaate for fremstilling derav.
DE69805772D1 (de) Stabilisierte mischung auf fibrinogenbasis
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
DE59504181D1 (de) Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
DE3587394D1 (de) Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder "acquired immune deficiency syndrome" (aids).
KR890000517A (ko) 하이브리드 단백질 c 및 이의 제조방법
DK0422937T3 (da) Fibrinogenreceptorantagonister
DK0711305T3 (da) Protegriner
BE904831A (fr) Composition d'activateur tissulaire du plasminogene.
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
BR9803914A (pt) Lantibióticos relacionados a actagardina e processos para sua preparação e uso.
DE3481386D1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
DK0383599T3 (da) Protein-anticancermiddel
GB8820378D0 (en) Chemical compounds
ATE111918T1 (de) Spezifische spaltung von peptidbindungen durch organische tertiäre phosphine mit nukleophilen seitenketten.
Juszkiewicz Ultrasonic studies on hydration of carboxylic acids, amino acids and peptides in aqueous ethanolic solutions
DE69421849D1 (de) Verfahren zur Herstellung von alpha,omega-Diaminosäuren abgeleiteten Harnstoffen
KR900701834A (ko) 사람 호중구 화학주성 인자를 사람에게 투여하는 것에 의한 면역결핍 상태에 의해 유발된 질병의 치료방법

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: BIOCHEM IMMUNOSYSTEMS INC., MONTREAL, QUEBEC, CA

8327 Change in the person/name/address of the patent owner

Owner name: ADALTIS INC., MONTREAL, QUEBEC, CH

8366 Restricted maintained after opposition proceedings